Delivery Order SPE2DB22D2206-SPE2DB24FFJ12
- Not listed
- This federal contract award, valued at $34,256.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 40 mg tablets in 500-count bottles. This is a firm-fixed-price delivery order with a completion date of September 26, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of 4,560,678,255 units of Rosuvastatin Calcium 10 mg tablets. The $1,305.52 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, under contract number SPE2DX15D1205|SPE2DX23F56W7. The contract has an ultimate completion date of April 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $18,351.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 40 mg tablets in quantities of 500 per bottle. It is a Firm Fixed Price Delivery Order contract with a completion date of May 10, 2024. There was no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,020.10 delivery order is for Rosuvastatin Calcium 5 mg tablets, a cardiovascular medication. This award falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,563,448,409 Rosuvastatin Calcium 10 mg tablets in 1,000-count bottles. The $4,138.94 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.30 delivery order contract is for the supply of Rosuvastatin Calcium 10 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of September 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $157,458.83 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,669.34, is a delivery order for the supply of 1,000 tablets of Rosuvastatin Calcium 20 mg. The contract has an ultimate completion date of December 5, 2023 and is a firm-fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products...
- This federal contract award, valued at $11,696.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFJ12Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $54,303.29, is for the delivery of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The contract has an ultimate completion date of January 31, 2024 and is a firm fixed-price delivery order. No set-aside designation was used, indicating open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical and prescription drug procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.3k | 1/30/24 |